1-10 of 10
Retraction Statement
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Retraction Statement

Free
Subject Area:
Pharmacology
Journal: Pharmacology
Pharmacology (2025)
https://doi.org/10.1159/000545109
Published Online: 29 April 2025
View articletitled, Retraction Statement
Open the PDF for Retraction Statement in another window
Journal Articles

Retraction Statement

Free
Subject Area:
Pharmacology
Journal: Pharmacology
Pharmacology (2025)
https://doi.org/10.1159/000544828
Published Online: 11 April 2025
View articletitled, Retraction Statement
Open the PDF for Retraction Statement in another window
Journal Articles

Retraction Statement: Paper by Wenjun Li, Xiaonu Peng, Zhaoyang Wang, Hongwei Zhang, Haibo Huang, Huimin Liu, and Li Cai entitled “The Long Noncoding RNA, Growth Arrest-Specific 5, Suppresses Gastric Cancer by Downregulating miR-21 Expression” [Pharmacology. 2020;105(7–8):434–44; DOI: 10.1159/000504674]

Free
Subject Area:
Pharmacology
Journal: Pharmacology
Pharmacology (2025) 110 (1): 62.
https://doi.org/10.1159/000542299
Published Online: 05 November 2024
View articletitled, Retraction Statement: Paper by Wenjun Li, Xiaonu Peng, Zhaoyang Wang, Hongwei Zhang, Haibo Huang, Huimin Liu, and Li Cai entitled “The Long Noncoding RNA, Growth Arrest-Specific 5, Suppresses Gastric Cancer by Downregulating miR-21 Expression” [Pharmacology. 2020;105(7–8):434–44; DOI: 10.1159/000504674]
Open the PDF for Retraction Statement: Paper by Wenjun Li, Xiaonu Peng, Zhaoyang Wang, Hongwei Zhang, Haibo Huang, Huimin Liu, and Li Cai entitled “The Long Noncoding RNA, Growth Arrest-Specific 5, Suppresses Gastric Cancer by Downregulating miR-21 Expression” [Pharmacology. 2020;105(7–8):434–44; DOI: 10.1159/000504674] in another window
Journal Articles

Retraction Statement: Paper by Zhe Bai, Xiao-Hui Guo, Chi Tang, Si-Tong Yue, Long Shi and Bo Qiang entitled “Effects of Artesunate on the Expressions of Insulin-Like Growth Factor-1, Osteopontin and C-Telopeptides of Type II Collagen in a Rat Model of Osteoarthritis” [Pharmacology. 2017;101(1–2):1–8, https://doi.org/10.1159/000479160]

Free
Subject Area:
Pharmacology
Journal: Pharmacology
Pharmacology (2024) 109 (6): 365.
https://doi.org/10.1159/000540933
Published Online: 03 September 2024
View articletitled, Retraction Statement: Paper by Zhe Bai, Xiao-Hui Guo, Chi Tang, Si-Tong Yue, Long Shi and Bo Qiang entitled “Effects of Artesunate on the Expressions of Insulin-Like Growth Factor-1, Osteopontin and C-Telopeptides of Type II Collagen in a Rat Model of Osteoarthritis” [Pharmacology. 2017;101(1–2):1–8, https://doi.org/10.1159/000479160]
Open the PDF for Retraction Statement: Paper by Zhe Bai, Xiao-Hui Guo, Chi Tang, Si-Tong Yue, Long Shi and Bo Qiang entitled “Effects of Artesunate on the Expressions of Insulin-Like Growth Factor-1, Osteopontin and C-Telopeptides of Type II Collagen in a Rat Model of Osteoarthritis” [Pharmacology. 2017;101(1–2):1–8, https://doi.org/10.1159/000479160] in another window
Journal Articles

Retraction Statement: Paper by Zheng Ding, Huifeng Shi and Wei Yang entitled “Osteoprotective Effect of Cimiracemate in Glucocorticoid-Induced Osteoporosis by Osteoprotegerin/Receptor Activator of Nuclear Factor κ B/Receptor Activator of Nuclear Factor Kappa-Β Ligand Signaling” [Pharmacology. 2019;103(3–4):163–72; DOI: 10.1159/000495509]

Free
Subject Area:
Pharmacology
Journal: Pharmacology
Pharmacology (2024) 109 (3): 181.
https://doi.org/10.1159/000539157
Published Online: 06 May 2024
View articletitled, Retraction Statement: Paper by Zheng Ding, Huifeng Shi and Wei Yang entitled “Osteoprotective Effect of Cimiracemate in Glucocorticoid-Induced Osteoporosis by Osteoprotegerin/Receptor Activator of Nuclear Factor κ B/Receptor Activator of Nuclear Factor Kappa-Β Ligand Signaling” [Pharmacology. 2019;103(3–4):163–72; DOI: 10.1159/000495509]
Open the PDF for Retraction Statement: Paper by Zheng Ding, Huifeng Shi and Wei Yang entitled “Osteoprotective Effect of Cimiracemate in Glucocorticoid-Induced Osteoporosis by Osteoprotegerin/Receptor Activator of Nuclear Factor κ B/Receptor Activator of Nuclear Factor Kappa-Β Ligand Signaling” [Pharmacology. 2019;103(3–4):163–72; DOI: 10.1159/000495509] in another window
Journal Articles

Retraction Statement: Paper by Lingyan Qiao, Yusheng Liu, Cheng Li, Juan Ge and Tang Li entitled “Regulation of iRhom-2/Tumor Necrosis Factor-α Converting Enzyme Pathway and Oxidative Stress Protects the Renal Injury with Anemonin in Streptozotocin-Induced Diabetic Nephropathy Neonatal Rat Model” [Pharmacology. 2019;104(5–6):258–266; DOI: 10.1159/000501631]

Free
Subject Area:
Pharmacology
Journal: Pharmacology
Pharmacology (2024) 109 (3): 182.
https://doi.org/10.1159/000538990
Published Online: 25 April 2024
View articletitled, Retraction Statement: Paper by Lingyan Qiao, Yusheng Liu, Cheng Li, Juan Ge and Tang Li entitled “Regulation of iRhom-2/Tumor Necrosis Factor-α Converting Enzyme Pathway and Oxidative Stress Protects the Renal Injury with Anemonin in Streptozotocin-Induced Diabetic Nephropathy Neonatal Rat Model” [Pharmacology. 2019;104(5–6):258–266; DOI: 10.1159/000501631]
Open the PDF for Retraction Statement: Paper by Lingyan Qiao, Yusheng Liu, Cheng Li, Juan Ge and Tang Li entitled “Regulation of iRhom-2/Tumor Necrosis Factor-α Converting Enzyme Pathway and Oxidative Stress Protects the Renal Injury with Anemonin in Streptozotocin-Induced Diabetic Nephropathy Neonatal Rat Model” [Pharmacology. 2019;104(5–6):258–266; DOI: 10.1159/000501631] in another window
Journal Articles

Retraction Statement: Paper by Tong Chen, Bo Zhang, Yuan Lin, Jiang Pan, Xiao-Xiong Zhao and Shi-Xiang Ren entitled “Protective Effects of Prunasin A against the Differentiation of Osteoclasts and Destruction of Cartilage via the Receptor Activator of Nuclear Factor-Kappa-Β Ligand/Mitogen-Activated Protein Kinase/Osteoprotegerin Pathway in a Rat Model of Arthritis” [Pharmacology. 2019;104(5–6):216–25; DOI: 10.1159/000502537]

Free
Subject Area:
Pharmacology
Journal: Pharmacology
Pharmacology (2024) 109 (2): 127.
https://doi.org/10.1159/000538004
Published Online: 01 March 2024
View articletitled, Retraction Statement: Paper by Tong Chen, Bo Zhang, Yuan Lin, Jiang Pan, Xiao-Xiong Zhao and Shi-Xiang Ren entitled “Protective Effects of Prunasin A against the Differentiation of Osteoclasts and Destruction of Cartilage via the Receptor Activator of Nuclear Factor-Kappa-Β Ligand/Mitogen-Activated Protein Kinase/Osteoprotegerin Pathway in a Rat Model of Arthritis” [Pharmacology. 2019;104(5–6):216–25; DOI: 10.1159/000502537]
Open the PDF for Retraction Statement: Paper by Tong Chen, Bo Zhang, Yuan Lin, Jiang Pan, Xiao-Xiong Zhao and Shi-Xiang Ren entitled “Protective Effects of Prunasin A against the Differentiation of Osteoclasts and Destruction of Cartilage via the Receptor Activator of Nuclear Factor-Kappa-Β Ligand/Mitogen-Activated Protein Kinase/Osteoprotegerin Pathway in a Rat Model of Arthritis” [Pharmacology. 2019;104(5–6):216–25; DOI: 10.1159/000502537] in another window
Journal Articles

Retraction Statement: Paper by Can Wei, Zhengfang Liu, Luchao Li, Yanbin Zhang, Zhiqing Fang, and Yidong Fan entitled “The Anticancer Effect of Huaier Extract in Renal Cancer 786-O Cells” [Pharmacology 2018;102(5–6):316–323, https://doi.org/10.1159/000492935]

Free
Subject Area:
Pharmacology
Journal: Pharmacology
Pharmacology (2024) 109 (1): 66.
https://doi.org/10.1159/000535412
Published Online: 24 November 2023
View articletitled, Retraction Statement: Paper by Can Wei, Zhengfang Liu, Luchao Li, Yanbin Zhang, Zhiqing Fang, and Yidong Fan entitled “The Anticancer Effect of Huaier Extract in Renal Cancer 786-O Cells” [Pharmacology 2018;102(5–6):316–323, https://doi.org/10.1159/000492935]
Open the PDF for Retraction Statement: Paper by Can Wei, Zhengfang Liu, Luchao Li, Yanbin Zhang, Zhiqing Fang, and Yidong Fan entitled “The Anticancer Effect of Huaier Extract in Renal Cancer 786-O Cells” [Pharmacology 2018;102(5–6):316–323, https://doi.org/10.1159/000492935] in another window
Journal Articles

Retraction Statement: Paper by Ruijuan Zhou, Shifeng Kan, Song Cai, Ran Sun, Haixin Yuan, and Bo Yu entitled “Scopoletin Activates Adenosine Monophosphate-Activated Protein Kinase/Mammalian Target of Rapamycin Signaling Pathway and Improves Functional Recovery after Spinal Cord Injury in Rats” [Pharmacology 2020;105(5–6):349–359, https://doi.org/10.1159/000503866]

Free
Subject Area:
Pharmacology
Journal: Pharmacology
Pharmacology (2024) 109 (1): 65.
https://doi.org/10.1159/000534434
Published Online: 12 October 2023
View articletitled, Retraction Statement: Paper by Ruijuan Zhou, Shifeng Kan, Song Cai, Ran Sun, Haixin Yuan, and Bo Yu entitled “Scopoletin Activates Adenosine Monophosphate-Activated Protein Kinase/Mammalian Target of Rapamycin Signaling Pathway and Improves Functional Recovery after Spinal Cord Injury in Rats” [Pharmacology 2020;105(5–6):349–359, https://doi.org/10.1159/000503866]
Open the PDF for Retraction Statement: Paper by Ruijuan Zhou, Shifeng Kan, Song Cai, Ran Sun, Haixin Yuan, and Bo Yu entitled “Scopoletin Activates Adenosine Monophosphate-Activated Protein Kinase/Mammalian Target of Rapamycin Signaling Pathway and Improves Functional Recovery after Spinal Cord Injury in Rats” [Pharmacology 2020;105(5–6):349–359, https://doi.org/10.1159/000503866] in another window
Journal Articles

Retraction Statement: Paper by Bin Xu, Tangpeng Xu, Huali Liu, Qian Min, Shidong Wang and Qibin Song entitled “MiR-490-5p Suppresses Cell Proliferation and Invasion by Targeting BUB1 in Hepatocellular Carcinoma Cells” [Pharmacology. 2017;100:269–282, DOI: 10.1159/000477667]

Free
Subject Area:
Karger e-Journal Backfile Collection 2023 , Pharmacology
Journal: Pharmacology
Pharmacology (2023) 108 (5): 495–496.
https://doi.org/10.1159/000531416
Published Online: 22 June 2023
View articletitled, Retraction Statement: Paper by Bin Xu, Tangpeng Xu, Huali Liu, Qian Min, Shidong Wang and Qibin Song entitled “MiR-490-5p Suppresses Cell Proliferation and Invasion by Targeting BUB1 in Hepatocellular Carcinoma Cells” [Pharmacology. 2017;100:269–282, DOI: 10.1159/000477667]
Open the PDF for Retraction Statement: Paper by Bin Xu, Tangpeng Xu, Huali Liu, Qian Min, Shidong Wang and Qibin Song entitled “MiR-490-5p Suppresses Cell Proliferation and Invasion by Targeting BUB1 in Hepatocellular Carcinoma Cells” [Pharmacology. 2017;100:269–282, DOI: 10.1159/000477667] in another window